| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 01/12/1999 | US5858670 Screening randomly synthesized oligopeptide- or oligonucleotide-solid phase libraries with acceptor molecules (e.g. antibodies), isolating solid phase support/oligomer bound to molecule, sequencing oligomer |
| 01/12/1999 | US5858360 Mediate embryo-endometrium adhesion; anti-trophinin antibodies for inhibition; trophinin-assisting proteins tastin, bystin, lastin for increasing binding; endometrial adenocarcinoma |
| 01/07/1999 | WO1999032511A1 PEPTIDES, METHOD FOR ASSAYING HUMAN PEPSINOGEN II or HUMAN PEPSIN II, AND ASSAYING KIT |
| 01/07/1999 | WO1999000406A1 CYCLIC AGONISTS AND ANTAGONISTS OF C5a RECEPTORS AND G PROTEIN-COUPLED RECEPTORS |
| 01/07/1999 | WO1999000139A1 Antimicrobial agents from invertebrates |
| 01/07/1999 | WO1998045427A3 Insulin-like growth factor agonist peptides |
| 01/07/1999 | EP0889052A2 Immunoreactive peptides from Epstein-Barr virus |
| 01/07/1999 | EP0888543A1 Azatide peptidomimetics |
| 01/07/1999 | EP0888541A1 Cryptic peptides and method for their identification |
| 01/07/1999 | EP0888382A1 Chromatographic process for obtaining very pure cyclosporin a and related cyclosporins |
| 01/07/1999 | EP0888120A1 Hla binding peptides and their uses |
| 01/07/1999 | EP0888053A1 Method for treatment of cancer and infectious diseases and compositions useful in same |
| 01/07/1999 | EP0698040A4 Lhrh antagonists |
| 01/07/1999 | DE19728524A1 Cyclische Azapeptide Cyclic Azapeptide |
| 01/06/1999 | CN1204366A Antifungal protein |
| 01/06/1999 | CN1204343A Endothelial cell proliferation inhibitor and method of use |
| 01/06/1999 | CN1204342A Antineoplastic peptides |
| 01/06/1999 | CN1204341A Oligopeptide compounds containing D-2-alkyltryptophan capable of promoting release of growth hormone |
| 01/05/1999 | US5856448 Materials involved in the control of the cardiovascular system, and in particular to activities mediated by thrombin and its cellular receptor. |
| 01/05/1999 | US5856158 Used to degrad arginine to citrulline and nitric oxide |
| 01/05/1999 | US5856141 Irradiating to form hybrid |
| 01/05/1999 | US5856127 Antimicrobial peptides |
| 01/05/1999 | CA2078373C Peptides for the production of preparations for the diagnosis and therapy of systemic lupus |
| 12/30/1998 | WO1998058967A1 Self-assembling peptide surfaces for cell patterning and interactions |
| 12/30/1998 | WO1998058952A1 Angiotensin derivatives |
| 12/30/1998 | WO1998058951A1 Isolated nona- and decapeptides which bind to hla molecules, and the use thereof |
| 12/30/1998 | WO1998058950A1 Compounds with growth hormone releasing properties |
| 12/30/1998 | EP0886648A1 Compounds and peptides that bind to the erythropoietin receptor |
| 12/30/1998 | EP0705105A4 Metal chelates as spacer compounds in biologically active peptides |
| 12/30/1998 | EP0661999B1 Anti-feline immunodeficiency virus (fiv) vaccines |
| 12/30/1998 | EP0463059B1 Allergenic proteins from ragweed and uses therefor |
| 12/29/1998 | US5854389 Process for preparing modified proteins |
| 12/29/1998 | US5854388 Angiotensin IV peptides and receptor |
| 12/29/1998 | US5854276 Substance WF16616, process for production thereof, and use thereof |
| 12/29/1998 | US5854213 Antifungal cyclohexapeptides |
| 12/29/1998 | US5854212 Cyclohexapeptidyl bisamine compound, compositions containing said compound and methods of use |
| 12/29/1998 | US5854211 Compounds with growth hormone releasing properties |
| 12/29/1998 | US5854204 Aβ peptides that modulate β-amyloid aggregation |
| 12/29/1998 | US5854202 Peptide fragments of calreticulin, peptide mimetics thereof, and pharmaceutical compostions comprising same |
| 12/29/1998 | US5854003 Screening method for agents that modulate human NIK activity |
| 12/29/1998 | US5853713 Biologically compatible linear block copolymers of polyalkylene oxide and peptide units |
| 12/23/1998 | WO1998057994A2 Opsonic and protective monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria |
| 12/23/1998 | WO1998057991A1 Peptides and compounds that bind to the il-5 receptor |
| 12/23/1998 | WO1998057986A2 Human preprotachykinin b |
| 12/23/1998 | WO1998057980A1 Peptides and compounds that bind to the il-5 receptor |
| 12/23/1998 | WO1998057979A1 Peptides and compounds that bind to the il-5 receptor |
| 12/23/1998 | WO1998041535A3 Activation of peptides |
| 12/23/1998 | EP0885957A1 Process for the deacylation of cyclic lipopeptides |
| 12/23/1998 | EP0885904A1 Peptides as agonists and/or inhibitors of amyloid formation and/or cytotoxicity and their use against Alzheimer's disease, type II diabetes mellitus and spongiform encephalopathy |
| 12/23/1998 | EP0885900A2 Increasing blood-brain barrier permeability with permeabilizer peptide derivatives of bradykinin |
| 12/23/1998 | EP0885390A1 Affinity labeling libraries and applications thereof |
| 12/23/1998 | EP0885244A1 Peptide immunogens for vaccination against and treatment of allergy |
| 12/23/1998 | EP0885242A1 Peptides and compounds that bind to a thrombopoietin receptor |
| 12/23/1998 | EP0885189A2 Method for the synthesis of poly-pyrrole and poly-imidazole carboxamides on a solid support |
| 12/23/1998 | EP0885017A2 Use of labelled cck-b receptor ligands for the detection and localization of malignant human tumours |
| 12/23/1998 | EP0885011A2 Vaccines |
| 12/23/1998 | EP0728012A4 NOVEL GnRH ANALOGUES WITH ANTITUMOUR EFFECTS AND PHARMACEUTICAL COMPOSITIONS THEREOF |
| 12/23/1998 | EP0722459B1 Hemoregulatory penta- or hexapeptides |
| 12/23/1998 | EP0710246A4 Thrombin receptor radioligands and assays for identifying thrombin receptor antagonists |
| 12/23/1998 | EP0541629B1 Cloning and expression of a rhoptry associated protein of (p.falciparum) |
| 12/23/1998 | CN1202931A Tumour vaccine and process for the preparation thereof |
| 12/23/1998 | CN1202907A Cyclopeptide derivatives |
| 12/23/1998 | CN1202904A Cyclopeptolides |
| 12/23/1998 | CN1202903A Targeted cytotoxic anthracycline analogs |
| 12/23/1998 | CN1202882A New LH-RH antigonists with improved effectiveness |
| 12/23/1998 | CA2295994A1 Peptides and compounds that bind to the il-5 receptor |
| 12/23/1998 | CA2294519A1 Peptides and compounds that bind to the il-5 receptor |
| 12/23/1998 | CA2294435A1 Human preprotachykinin b |
| 12/23/1998 | CA2293732A1 Opsonic and protective monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria |
| 12/22/1998 | US5851523 Isolated, peptides derived from MAGE tumor rejection antigen precursors which complex with HLA-A2 molecules and uses thereof |
| 12/17/1998 | WO1998057174A1 Synthetic antibiotics |
| 12/17/1998 | WO1998056919A2 Methods and reagents for vaccination which generate a cd8 t cell immune response |
| 12/17/1998 | WO1998056809A1 Physiologically active polyoxypeptin and deoxypolyoxypeptin and anticancer drugs containing the same |
| 12/17/1998 | WO1998056401A1 Cd28/ctla-4 inhibiting peptidomimetics, pharmaceutical compositions thereof, and method of using same |
| 12/17/1998 | WO1998051325A3 Random peptides that bind to gastro-intestinal tract (git) transport receptors and related methods |
| 12/17/1998 | WO1998040401A3 Compositions and methods for treating infections using cationic peptides alone or in combination with antibiotics |
| 12/17/1998 | DE19725368A1 New cyclic peptides inhibit ligand binding to integrins |
| 12/17/1998 | CA2293828A1 Physiologically active polyoxypeptin and deoxypolyoxypeptin and anticancer drugs containing the same |
| 12/17/1998 | CA2293666A1 Cd28/ctla-4 inhibiting peptidomimetics, pharmaceutical compositions thereof, and method of using same |
| 12/17/1998 | CA2240005A1 Peptides acting as agonists and inhibitors of amyloid formation and cytotoxicity for therapeutic use with alzeheimer's disease, type ii diabetes mellitus and spongiform encephalopathies |
| 12/16/1998 | EP0884328A1 Binding partners for collagen degradation peptides, and their use |
| 12/16/1998 | EP0884055A1 Binding partners for collagen-derived peptide compositions, and their use |
| 12/16/1998 | EP0883602A2 Lipids and their use, for example, in liposomes |
| 12/16/1998 | CN1202200A Fas ligang fusion protein |
| 12/16/1998 | CN1202175A Mimotopes and anti-mimotopes of human platelet glycoprotein Ib/Ix |
| 12/15/1998 | US5849954 Method of peptide synthesis |
| 12/15/1998 | US5849896 α-subunit of the Mac-1 leukocyte adhesion receptor |
| 12/15/1998 | US5849893 Nucleic acid-binding oligomers possessing C-branching for therapy and diagnostics |
| 12/15/1998 | US5849865 Peptides for altering bone resorption, angiogenesis and restenosis |
| 12/15/1998 | US5849863 Cytolytic bradykinin antagonists |
| 12/15/1998 | US5849701 Peptide inhibitors of fibronectin and related collagen-binding proteins |
| 12/15/1998 | US5849693 Cyclic compounds linked by a heterocyclic ring useful as inhibitors of platelet glycoprotein IIb/IIIa |
| 12/15/1998 | US5849692 Cyclic peptides containing Arg-Gly-Asp, and derivatives thereof, as adhesion inhibitors |
| 12/15/1998 | US5849691 Peptidomimetic inhibitors of cathepsin D and plasmepsins I and II |
| 12/15/1998 | US5849690 Anti-aggregatory peptides |
| 12/15/1998 | US5849548 Cell ablation using trans-splicing ribozymes |
| 12/15/1998 | US5849540 Thiodepsipeptide isolated from a marine actinomycete |
| 12/15/1998 | US5849529 Cellobiose phosphorylase gene, vector and transformant containing said gene |
| 12/15/1998 | US5849510 Factor Xa inhibitors |
| 12/15/1998 | US5849507 Methods to diagnose thrombosis by measuring activation peptide |